Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: novel pharmacological therapies ×

novel pharmacological therapies

This treatment is selected. Its supporting articles are shown below.

novel pharmacological therapies1

Articles mentioning novel pharmacological therapies

1 articles · page 1 of 1

Thrombospondin-2: a promising but unproven biomarker for MASH

gutjnl · abstract · 2025-11-12 · 1 matching annotations

77.4%

novel pharmacological therapies hepatocellular carcinoma semaglutide1 2 resmetirom type 2 diabetes Metabolic dysfunction-associated steatotic liver disease MASH metabolic dysfunction-associated steatohepatitis cirrhosis liver failure+1 more

…identify patients with fibrotic MASH who may be prioritised for novel pharmacological therapies.3 4…